TotalMarketCap

AC Immune

ACIUNasdaq SwitzerlandHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$212.707 M

$2.09 -8.73%

Close of 6 Nov 2026

As of 6 Nov 2026, AC Immune (ACIU) has a market capitalization of $212.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

101,742,231

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #241Greenwich LifeSciencesGLSI$214.6M
  2. #242Siga TechnologiesSIGA$213.0M
  3. #243AC ImmuneACIU$212.7M
  4. #244ADC TherapeuticsADCT$207.5M
  5. #245Sol-Gel TechnologiesSLGL$206.3M

What if AC Immune were worth as much as…

Open the what-if tool →

Gold $28.2T

$277,448.00

Per share 132,750× higher

Bitcoin $1.53T

$15,012.23

Per share 7,183× higher

Apple $5.02T

$49,283.74

Per share 23,581× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for AC Immune are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.